Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.33

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: greedsgd_2000 who wrote (1636)	9/14/2000 10:19:58 PM
From: PuddleGlum	Read Replies (2) of 52153

I keep thinking that ARIA has potentially disruptive technology, but the market doesn't agree with me ... yet. Other possibilities (IMHO): GERN, ILMN, ABGX, CEGE. And doesn't MYGN have some claim to fame here, in the same categories as NMPS? I thought that MYGN basically owned the breast cancer field. I wonder if most of the disruptive biotechs will be drug makers or picks & shovels plays? Peter, Biocosm discussion might get in the way of biotech valuation. Do you want this stuff on your thread? pg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next